{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:40:29Z","timestamp":1762674029893},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T00:00:00Z","timestamp":1429056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0119629","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T19:27:42Z","timestamp":1429126062000},"page":"e0119629","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"pactr2010050002122368","registry":"10.18810\/pactr"}],"author":[{"given":"Patricia. J.","family":"Munseri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"Kroidl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotta","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agricola","family":"Joachim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"Geldmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candida","family":"Moshiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Aboud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eligius","family":"Lyamuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Maboko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Missanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahati","family":"Kaluwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayoki","family":"Mfinanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilly","family":"Podola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asli","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Godoy-Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Marovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hoelscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Gotch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"St\u00f6hr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Stout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Wahren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Mhalu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merlin L.","family":"Robb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnel","family":"Biberfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Sandstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Bakari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,4,15]]},"reference":[{"key":"ref1","unstructured":"UNAIDS (2013) UNAIDS report on the global AIDS epidemic 2013."},{"key":"ref2","unstructured":"UNAIDS (2014) Fast-TracK: Ending the AIDS Epidemic by 2030."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Q Abdool Karim","year":"2010","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"18591","DOI":"10.7448\/IAS.16.1.18591","article-title":"Inconsistent condom use among HIV-positive women in the "Treatment as Prevention Era": data from the Italian DIDI study","volume":"16","author":"P Cicconi","year":"2013","journal-title":"J Int AIDS Soc"},{"issue":"Suppl 1","key":"ref5","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/QAI.0b013e31829202a2","article-title":"Translation of biomedical prevention strategies for HIV: prospects and pitfalls","volume":"63","author":"SH Vermund","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMp1313771","article-title":"Ending AIDS\u2014is an HIV vaccine necessary?","volume":"370","author":"AS Fauci","year":"2014","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"ref7","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/cid\/ciu420","article-title":"Ending the global HIV\/AIDS pandemic: the critical role of an HIV vaccine","volume":"59","author":"AS Fauci","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/QAD.0b013e32835474d2","article-title":"The design and evaluation of HIV-1 vaccines","volume":"26","author":"KO Saunders","year":"2012","journal-title":"AIDS"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/infdis\/jir199","article-title":"Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA\/modified vaccinia Ankara simian immunodeficiency virus vaccine","volume":"204","author":"L Lai","year":"2011","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"81ra36","DOI":"10.1126\/scitranslmed.3002351","article-title":"Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys","volume":"3","author":"NL Letvin","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature10766","article-title":"Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys","volume":"482","author":"DH Barouch","year":"2012","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12026-010-8177-7","article-title":"CD8(+)T-cell-mediated control of HIV-1 and SIV infection","volume":"49","author":"SA Freel","year":"2011","journal-title":"Immunol Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"123ra125","DOI":"10.1126\/scitranslmed.3003165","article-title":"HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome","volume":"4","author":"DZ Soghoian","year":"2012","journal-title":"Sci Transl Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"a007351","DOI":"10.1101\/cshperspect.a007351","article-title":"Human immunodeficiency virus vaccine trials","volume":"2","author":"RJ O'Connell","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/COH.0b013e32833d17ac","article-title":"HIV vaccines: lessons learned and the way forward","volume":"5","author":"JH Kim","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"BF Haynes","year":"2012","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/COH.0b013e3283632c26","article-title":"Novel directions in HIV-1 vaccines revealed from clinical trials","volume":"8","author":"JL Excler","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm.2529","article-title":"Moving ahead an HIV vaccine: use both arms to beat HIV","volume":"17","author":"BD Walker","year":"2011","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1016\/j.vaccine.2011.08.001","article-title":"Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania","volume":"29","author":"M Bakari","year":"2011","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1086\/592507","article-title":"Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara","volume":"198","author":"E Sandstrom","year":"2008","journal-title":"J Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/aid.2013.0149","article-title":"Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees","volume":"30","author":"C Nilsson","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.ymthe.2005.06.473","article-title":"Multigene\/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery","volume":"12","author":"A Brave","year":"2005","journal-title":"Mol Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1016\/j.vaccine.2005.08.018","article-title":"Reduced cellular immune responses following immunization with a multi-gene HIV-1 vaccine","volume":"24","author":"A Brave","year":"2006","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1016\/j.vaccine.2009.07.039","article-title":"Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines","volume":"27","author":"PL Earl","year":"2009","journal-title":"Vaccine"},{"key":"ref26","article-title":"Division of AIDS Table for Grading The Severity of Adult and Pediatric Adverse Events","year":"2004"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-1759(01)00535-X","article-title":"A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays","volume":"260","author":"JR Currier","year":"2002","journal-title":"J Immunol Methods"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/lc.1999.v133.a94931","article-title":"Benign ethnic neutropenia: what is a normal absolute neutrophil count?","volume":"133","author":"TB Haddy","year":"1999","journal-title":"J Lab Clin Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e3327","DOI":"10.1371\/journal.pone.0003327","article-title":"Reference ranges for the clinical laboratory derived from a rural population in Kericho, Kenya","volume":"3","author":"RS Kibaya","year":"2008","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e3919","DOI":"10.1371\/journal.pone.0003919","article-title":"Reference intervals in healthy adult Ugandan blood donors and their impact on conducting international vaccine trials","volume":"3","author":"LA Eller","year":"2008","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e45840","DOI":"10.1371\/journal.pone.0045840","article-title":"Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens","volume":"7","author":"S Ratto-Kim","year":"2012","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/jiq105","article-title":"Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles","volume":"203","author":"PA Goepfert","year":"2011","journal-title":"J Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e55831","DOI":"10.1371\/journal.pone.0055831","article-title":"Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteers","volume":"8","author":"S Mehendale","year":"2013","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0119629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T03:17:24Z","timestamp":1588994244000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0119629"}},"subtitle":[],"editor":[{"given":"Paul A","family":"Goepfert","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,15]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0119629","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,15]]}}}